Research groups
Colleges
Frances Platt
FRS FMedSci
Head of Department
- Professor of Biochemistry and Pharmacology
Professor Platt obtained a BSc in Zoology at Imperial College University of London and a PhD in animal physiology from the University of Bath. She was a post-doctoral fellow at Washington University Medical School in St Louis, USA. She returned to the UK in 1989 (to the Biochemistry Department, University of Oxford) where she focused on how the abnormal accumulation of glycosphingolipids results in pathology in lysosomal storage diseases.
She was a Lister Institute Senior Research Fellow from 1996-2002. A major focus of her work has been on the development of substrate reduction therapy (SRT) to treat several of these disorders. Proof of principle of SRT was demonstrated in mouse models of these primarily neurodegenerative diseases. Dr Platt’s research, in collaboration with Dr Terry Butters, has led to the development of the approved drug miglustat/Zavesca for glycosphingolipid storage disease therapy.
Her current interests focus on the cell biology and pathobiology of glycosphingolipids and on the development of novel therapies for treating diseases resulting from defects in gycolipid metabolism and lysosomal dysfunction.
She moved to the Department of Pharmacology in April 2006 and was elected a fellow of the Academy of Medical Sciences in 2011.
Key Research Areas:
- Lysosomal storage disorders, pathogenesis and therapy
- The effects of lysosomal storage on the immune system
- Development of biomarkers for monitoring storage disease patients
- Lysosomal dysfunction in more common diseases
Recent publications
-
Glucosamine Amends CNS Pathology in Mucopolysaccharidosis IIIC Mouse Expressing Misfolded HGSNAT
Journal article
PLATT F., (2022), Journal of Clinical Investigation
-
Increasing Diversity in Admissions to Postgraduate Study.
Journal article
Conway SJ. et al, (2022), J Med Chem, 65, 5867 - 5869
-
Current methods to analyse lysosome morphology, positioning, motility and function
Journal article
PLATT F., (2022), Traffic
-
Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression
Journal article
PLATT F., (2022), Scientific Reports
-
Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C
Journal article
PLATT F., (2022), Wellcome Open Research
-
NEONATAL LETHALITY AND GENETIC MODIFIERS IN A NEW MOUSE MODEL OF NIEMANN-PICK DISEASE, TYPE C
Conference paper
Rodriguez-Gil JL. et al, (2022), JOURNAL OF INVESTIGATIVE MEDICINE, 70, 300 - 300
-
Identification of genetic modifiers of murine hepatic β-glucocerebrosidase activity.
Journal article
Durán A. et al, (2021), Biochem Biophys Rep, 28